This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05303519
Brief Title: Safusidenib Phase 2 Study in IDH1 Mutant Glioma

First Submitted : March 13, 2022
First Submitted that Met QC Criteria : March 21, 2022
First Posted : March 31, 2022

Last Update Submitted that Met QC Criteria : November 13, 2023
Last Update Posted : November 14, 2023